Publication:
The use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments.

dc.contributor.authorFrometa-Castillo, Terman
dc.contributor.authorPyakuryal, Anil
dc.contributor.authorNarayanasamy, Ganesh
dc.contributor.authorMesbahi, Asghar
dc.contributor.authorWals-Zurita, Amadeo
dc.date.accessioned2023-05-03T14:27:24Z
dc.date.available2023-05-03T14:27:24Z
dc.date.issued2022-09-19
dc.description.abstractThe NTCP methodology evaluating side-effects (S-Es) was initially used in radiotherapy (RT), and later was extended to brachytherapy (BT). The NTCP0 methodology has been recently introduced in RT. Given the advantages, this methodology could replace NTCP. Revisions of studies related to use of NTCP in the evaluations of S-Es in BT. Development of the first versions of two Matlab applications of the NTCP0 methodology. These applications have three options. Two of them employ the well-known aspects of a phenomenological model, or the probabilistic relationship between NTCP0 and total NTCP (TNTCP) that is the sum(NTCP(xi)) i: ithcomplication i:1..nc: Number of complications; where NTCP0 = 100% - TNTCP; and the third option assumes a NTCP(xi) discrete probabilistic distribution generated by the binomial distribution, where one of its parameters is automatically obtained from a databased of the Disease locations Vs. Late complications. The NTCP0cal and NTCP0calDr Matlab applications have been developed, and respectively used for fractional continuous low dose-rate BT. NTCP0 is defined as the ratio of the number of patients without acute/late complications and total of them, and also can be obtained using our Matlab applications. NTCP0 works do not disregard the last 10-15 years of NTCP research; but NTCP0 was not considered during these years. A generic example was used for showing the variations of the late complications and NTCP0 for a BT treatment of a constant number of fractions and six different dose per fraction values.
dc.identifier.doi10.5603/RPOR.a2022.0063
dc.identifier.issn1507-1367
dc.identifier.pmcPMC9521694
dc.identifier.pmid36196423
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521694/pdf
dc.identifier.unpaywallURLhttps://journals.viamedica.pl/rpor/article/download/RPOR.a2022.0063/68846
dc.identifier.urihttp://hdl.handle.net/10668/21665
dc.issue.number4
dc.journal.titleReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
dc.journal.titleabbreviationRep Pract Oncol Radiother
dc.language.isoen
dc.organizationHospital Universitario Virgen Macarena
dc.page.number602-609
dc.pubmedtypeJournal Article
dc.rights.accessRightsopen access
dc.subjectLKB NTCP model
dc.subjectNTCP
dc.subjectbinomial distribution
dc.subjectbrachytherapy
dc.subjectside-effect
dc.titleThe use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number27
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC9521694.pdf
Size:
369.33 KB
Format:
Adobe Portable Document Format